BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32289153)

  • 1. Hide and seek: Somatic SMAD3 mutations in melorheostosis.
    Velchev JD; Verstraeten A; Loeys B
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32289153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
    Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis.
    De Ridder R; Boudin E; Zillikens MC; Ibrahim J; van der Eerden BCJ; Van Hul W; Mortier G
    Bone; 2020 Aug; 137():115406. PubMed ID: 32387835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.
    Wordsworth P; Chan M
    Calcif Tissue Int; 2019 May; 104(5):530-543. PubMed ID: 30989250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.
    Schiro MM; Stauber SE; Peterson TL; Krueger C; Darnell SJ; Satyshur KA; Drinkwater NR; Newton MA; Hoffmann FM
    PLoS One; 2011; 6(9):e25021. PubMed ID: 21949838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
    Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
    Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
    J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib.
    Zhang L; Li QX; Wu HL; Lu X; Yang M; Yu SY; Yuan XL
    Ann Oncol; 2014 Aug; 25(8):1584-90. PubMed ID: 24928833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
    Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
    Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic activating mutations in MAP2K1 cause melorheostosis.
    Kang H; Jha S; Deng Z; Fratzl-Zelman N; Cabral WA; Ivovic A; Meylan F; Hanson EP; Lange E; Katz J; Roschger P; Klaushofer K; Cowen EW; Siegel RM; Marini JC; Bhattacharyya T
    Nat Commun; 2018 Apr; 9(1):1390. PubMed ID: 29643386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of TGFβ Signaling for Effect of Fluoride on Osteoblastic Differentiation.
    Zhang J; Jiang N; Yu H; Yu X; Guo F; Zhao Z; Xu H
    Biol Trace Elem Res; 2019 Feb; 187(2):492-498. PubMed ID: 29770951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
    Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
    Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function.
    Lin HM; Lee JH; Yadav H; Kamaraju AK; Liu E; Zhigang D; Vieira A; Kim SJ; Collins H; Matschinsky F; Harlan DM; Roberts AB; Rane SG
    J Biol Chem; 2009 May; 284(18):12246-57. PubMed ID: 19265200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
    Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
    Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.
    Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J
    J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts.
    Abedini Bakhshmand E; Soltani BM
    Biol Chem; 2019 Apr; 400(5):677-685. PubMed ID: 30391930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular smooth muscle cells.
    Ohyama Y; Tanaka T; Shimizu T; Matsui H; Sato H; Koitabashi N; Doi H; Iso T; Arai M; Kurabayashi M
    J Atheroscler Thromb; 2012; 19(1):23-35. PubMed ID: 21986102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.
    Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K
    PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation.
    Chen J; Katz LH; Muñoz NM; Gu S; Shin JH; Jogunoori WS; Lee MH; Belkin MD; Kim SB; White JC; Andricovich J; Tzatsos A; Li S; Kim SS; Shetty K; Mishra B; Rashid A; Lee JS; Mishra L
    Sci Rep; 2016 Jul; 6():30217. PubMed ID: 27456065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.